海马萎缩与首发精神病未治疗时长及分子生物标志物的关联
该自然主义纵向研究纳入71例未用药首发非情感性精神病患者和73名匹配健康对照,约8周二代抗精神病药治疗后复评31例患者和32名对照。
要点
- 首发精神病患者基线左HVI已低于健康对照,提示结构改变在治疗前即存在。
- 约8周抗精神病药治疗期间左HVI年化下降4.1%,对照则轻度上升。
- 左HVI下降与DUP负相关,提示未治疗期越长萎缩可能越快。
核心结论
- 较长的DUP与初始治疗期间加速的海马萎缩相关,提示精神病对脑结构可能有持续、潜在有害的影响。
研究设计与样本
- 上海精神卫生中心开展的自然主义纵向研究,设年龄性别匹配健康对照。
- 2013年3月5日至2014年10月8日招募71例未用药首发非情感性精神病患者与73名对照。
- 约8周后复评31例患者和32名对照,患者按标准临床实践接受二代抗精神病药治疗。
主要发现
- 患者组基线左HVI中位数0.9275低于对照组的0.9512(点估计差-0.020,95%CI -0.029至-0.010,P=0.001)。
- 探索性分析显示左HVI与炎症、氧化应激、脑源性神经营养因子、胶质损伤及多巴胺能和谷氨酸能传递标志物相关。
临床怎么用
- 对首发精神病应重视DUP评估,缩短未治疗期可能有助于减少海马萎缩进展。
- 治疗初期可关注海马结构变化,但相关分子标志物尚属探索性,暂不宜用于临床决策。
局限性
- 约8周复评样本量较小(患者31例、对照32例),基线HVI分析样本亦少于总样本。
- 分子生物标志物与遗传分析为探索性,结论需后续研究重复验证。
- 右HVI变化与DUP的关联未达统计学显著,海马萎缩与DUP的因果关系尚不能确定。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
IMPORTANCE: Duration of untreated psychosis (DUP) has been associated with poor outcomes in schizophrenia, but the mechanism responsible for this association is not known. OBJECTIVES: To determine whether hippocampal volume loss occurs during the initial 8 weeks of antipsychotic treatment and whether it is associated with DUP, and to examine molecular biomarkers in association with hippocampal volume loss and DUP. DESIGN, SETTING, AND PARTICIPANTS: A naturalistic longitudinal study with matched healthy controls was conducted at Shanghai Mental Health Center. Between March 5, 2013, and October 8, 2014, 71 medication-naive individuals with nonaffective first-episode psychosis (FEP) and 73 age- and sex-matched healthy controls were recruited. After approximately 8 weeks, 31 participants with FEP and 32 controls were reassessed. EXPOSURES: The participants with FEP were treated according to standard clinical practice with second-generation antipsychotics. MAIN OUTCOMES AND MEASURES: Hippocampal volumetric integrity (HVI) (an automated estimate of the parenchymal fraction in a standardized hippocampal volume of interest), DUP, 13 peripheral molecular biomarkers, and 14 single-nucleotide polymorphisms from 12 candidate genes were determined. RESULTS: The full sample consisted of 71 individuals with FEP (39 women and 32 men; mean [SD] age, 25.2 [7.7] years) and 73 healthy controls (40 women and 33 men; mean [SD] age, 23.9 [6.4] years). Baseline median left HVI was lower in the FEP group (n = 57) compared with the controls (n = 54) (0.9275 vs 0.9512; difference in point estimate, -0.020 [95% CI, -0.029 to -0.010]; P = .001). During approximately 8 weeks of antipsychotic treatment, left HVI decreased in 24 participants with FEP at a median annualized rate of -.03791 (-4.1% annualized change from baseline) compared with an increase of 0.00115 (0.13% annualized change from baseline) in 31 controls (difference in point estimate, -0.0424 [95% CI, -0.0707 to -0.0164]; P = .001). The change in left HVI was inversely associated with DUP (r = -0.61; P = .002). Similar results were found for right HVI, although the association between change in right HVI and DUP did not achieve statistical significance (r = -0.35; P = .10). Exploratory analyses restricted to the left HVI revealed an association between left HVI and markers of inflammation, oxidative stress, brain-derived neurotrophic factor, glial injury, and markers reflecting dopaminergic and glutamatergic transmission. CONCLUSIONS AND RELEVANCE: An association between longer DUP and accelerated hippocampal atrophy during initial treatment suggests that psychosis may have persistent, possibly deleterious, effects on brain structure. Additional studies are needed to replicate these exploratory findings of molecular mechanisms by which untreated psychosis may affect hippocampal volume and to determine whether these effects account for the known association between longer DUP and poor outcome.
引用
- Goff DC, Zeng B, Ardekani BA, et al. Association of Hippocampal Atrophy With Duration of Untreated Psychosis and Molecular Biomarkers During Initial Antipsychotic Treatment of First-Episode Psychosis. JAMA Psychiatry. 2018. PMID: 29466532. doi:10.1001/jamapsychiatry.2017.4595
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。